Clinical trials
Phase 1 Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
109 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 10 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
| Terminated | 22 |
| Recruiting | 13 |
| Active, not recruiting | 9 |
| Withdrawn | 4 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 11 |
| Akamis Bio | 5 |
| Pfizer | 4 |
| Providence Health & Services | 4 |
| Amgen | 3 |
| Astellas Pharma Inc | 3 |
| Blueprint Medicines Corporation | 3 |
| Celgene | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| M.D. Anderson Cancer Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 109 |
| Neoplasms | 39 |
| Neoplasm Metastasis | 20 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Squamous Cell Carcinoma of Head and Neck | 13 |
| Adenocarcinoma | 11 |
| Sarcoma | 10 |
| Lymphoma | 9 |
| Lung Neoplasms | 8 |
| Melanoma | 8 |
Trials
Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.
9 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.